Stryker Corp. closed $35.40 below its 52-week high ($398.20), which the company reached on November 18th.

Johnson & Johnson agreed to acquire Intra-Cellular Therapies Inc., a company focused on treatments for central nervous system ...

Stryker's acquisition of Inari Medical strengthens its Neurovascular business, but its high valuation may warrant caution for ...

Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...

Irvine-based Inari Medical Inc. will be acquired by Stryker Corp. for $4.8 billion. The boards of directors of both companies ...

ABT gains a key position in point-of-care testing, focusing on Infectious Disease, Cardiometabolic & Informatics, Toxicology ...

We came across a bullish thesis on Stryker Corporation (SYK) on Business Model Mastery’s Substack by The Antifragile Investor ...

Insignia can function on three different tooth geometries, as well as unique size-specific collar lengths and market-leading ...

We recently published a list of Jim Cramer Discussed These 18 Stocks After Major AI Event. In this article, we are going to ...

It is not alone, as other health systems discover that reprocessing single-use medical devices can be a win-win for finances ...

Stryker (NYSE:SYK – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” ...